Kato Y - Search Results

1

Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study.

Ishida N, Katsura A, Takagaki K, Arakawa H, Shimada T, Mizuno S, Sai Y, Kato Y, Nakamura H, Suga Y, Matsushita R. Ishida N, et al. Among authors: kato y. BMC Oral Health. 2024 Aug 2;24(1):881. doi: 10.1186/s12903-024-04667-y. BMC Oral Health. 2024. PMID: 39095752 Free PMC article.

2

Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.

Li Q, Sai Y, Kato Y, Tamai I, Tsuji A. Li Q, et al. Among authors: kato y. Pharm Res. 2003 Aug;20(8):1119-24. doi: 10.1023/a:1025076326061. Pharm Res. 2003. PMID: 12948007

3

Transporter-mediated renal handling of nafamostat mesilate.

Li Q, Sai Y, Kato Y, Muraoka H, Tamai I, Tsuji A. Li Q, et al. Among authors: kato y. J Pharm Sci. 2004 Feb;93(2):262-72. doi: 10.1002/jps.10534. J Pharm Sci. 2004. PMID: 14705184

4

Characterization of renal excretion mechanism for a novel diuretic, M17055, in rats.

Nishimura T, Kato Y, Sai Y, Ogihara T, Tsuji A. Nishimura T, et al. Among authors: kato y. J Pharm Sci. 2004 Oct;93(10):2558-66. doi: 10.1002/jps.20165. J Pharm Sci. 2004. PMID: 15349965

5

Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population.

Kawasaki Y, Kato Y, Sai Y, Tsuji A. Kawasaki Y, et al. Among authors: kato y. J Pharm Sci. 2004 Dec;93(12):2920-6. doi: 10.1002/jps.20190. J Pharm Sci. 2004. PMID: 15459889

6

Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.

Inano A, Sai Y, Kato Y, Tamai I, Ishiguro M, Tsuji A. Inano A, et al. Among authors: kato y. Drug Metab Pharmacokinet. 2004 Jun;19(3):180-9. doi: 10.2133/dmpk.19.180. Drug Metab Pharmacokinet. 2004. PMID: 15499185 Free article.

7

PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2.

Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, Tsuji A. Kato Y, et al. Mol Pharmacol. 2005 Mar;67(3):734-43. doi: 10.1124/mol.104.002212. Epub 2004 Nov 2. Mol Pharmacol. 2005. PMID: 15523054

8

Screening of the interaction between xenobiotic transporters and PDZ proteins.

Kato Y, Yoshida K, Watanabe C, Sai Y, Tsuji A. Kato Y, et al. Pharm Res. 2004 Oct;21(10):1886-94. doi: 10.1023/b:pham.0000045244.83999.43. Pharm Res. 2004. PMID: 15553237

9

Multidrug resistance-associated protein 1 functions as an efflux pump of xenobiotics in the skin.

Li Q, Kato Y, Sai Y, Imai T, Tsuji A. Li Q, et al. Among authors: kato y. Pharm Res. 2005 Jun;22(6):842-6. doi: 10.1007/s11095-005-4576-1. Epub 2005 Jun 8. Pharm Res. 2005. PMID: 15948026

10

Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700.

Sai Y, Kato Y, Nakamura K, Kato S, Nishimura T, Kubo Y, Tamai I, Yang S, Hu Z, Yamada I, Tsuji A. Sai Y, et al. Among authors: kato s, kato y. J Pharm Sci. 2006 Feb;95(2):336-47. doi: 10.1002/jps.20540. J Pharm Sci. 2006. PMID: 16369928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,694 results

Search Page

Filters